Related Experiment Videos
Precursor T-lymphoblastic leukemia with a novel t(1;22)(p34;q13)
1Department of Pathology, Queen Elizabeth Hospital, 30 Gascoigne Road, Kowloon, Hong Kong SAR, China. kfwong@ha.org.hk
Cancer Genetics and Cytogenetics
|September 19, 2002
Summary
A novel chromosomal abnormality, t(1;22)(p34;q13), was identified in a patient with precursor T-lymphoblastic leukemia (T-ALL). This finding may represent a variant of a known T-ALL chromosomal abnormality.
Area of Science:
- Hematology
- Cytogenetics
- Oncology
Background:
- Precursor T-lymphoblastic leukemia (T-ALL) is an aggressive hematologic malignancy.
- Cytogenetic abnormalities play a crucial role in the diagnosis and prognosis of T-ALL.
Observation:
- A 37-year-old woman presented with cervical lymphadenopathy and leukocytosis.
- Diagnostic evaluation revealed precursor T-ALL.
Findings:
- Cytogenetic analysis of leukemic cells identified a novel karyotype: 46,XX, t(1;22)(p34;q13).
- This specific translocation, t(1;22)(p34;q13), has not been previously reported in human malignancies.
Implications:
- The t(1;22)(p34;q13) abnormality may be a variant of the t(1;14)(p34;q11) translocation commonly found in T-ALL.
- Identification of novel cytogenetic alterations in T-ALL contributes to a deeper understanding of leukemogenesis.
- Further research is warranted to elucidate the clinical significance and biological impact of this new chromosomal abnormality.